Survivors of Childhood Cancers Treated with Cyclophosphamide More Likely to Develop Bladder Cancer

	Tweet

Survivors of Childhood Cancers Treated with Cyclophosphamide More Likely to Develop Bladder Cancer Later in Life

Survivors of childhood cancers treated with the chemotherapy drug cyclophosphamide were five times more likely to develop bladder cancer later in life than the general population. Results of this new research from the United Kingdom were presented today during the Annual Scientific Meeting of the American Urological Association (AUA). Survivors originally diagnosed at zero to four years of age and those diagnosed with retinoblastoma, leukemia and non-Hodgkin’s lymphoma were at a particularly higher risk.

Researchers presented their findings to the media during a special press conference on May 19, 2008 at 3:00 p.m.

Researchers analyzed British Childhood Cancer Survivor Study (BCCSS) records of patients diagnosed under the age of 15 with leukemia, non-Hodgkin’s lymphoma, retinoblastoma or soft tissue sarcoma and subsequently treated with cyclophosphamide or radiotherapy. Patients in the study cohort had a survival rate of at least five years. These data were compared to records from the National Health Service Central Register through 2004 to identify patients who subsequently developed bladder cancer to determine whether treatment choice could be associated with future bladder cancer development.

Bladder cancer was found in 19 patients (5.3 times what was expected), with a mean follow up (post-five-year survival) of 18.9 years. Further analysis of follow-up intervals (20, 30, 40 and 50 years post-five-year survival) indicated that the risk of developing bladder cancer increases with time. The cumulative percentage of survivors diagnosed at 20, 30, 40 and 50 years was 0.02 percent, 0.08 percent, 0.37 percent and 0.71 percent, respectively.

Cyclophosphamide, an immunosuppressive drug used to treat several types of cancer, is known to cause bladder damage that predisposes patients to subsequent bladder cancer.

In addition to the author, Anthony Y. Smith, M.D., a member of the AUA Public Media Committee, will be on hand to provide expert commentary on the studies.

Gurung PM, Leiper A, Woodhouse CRJ, Hawkins MM: Risk of bladder cancer after childhood cancer. J Urol, suppl., 2008; 179: 322, abstract 934.

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is the pre-eminent professional organization for urologists, with more than 15,000 members throughout the world. An educational nonprofit organization, the AUA pursues its mission of fostering the highest standards of urologic care by carrying out a wide variety of programs members and their patients, including UrologyHealth.org, an award-winning on-line patient education resource, and the American Urological Association Foundation, Inc.

Source: American Urological Association (AUA)

RELATED STORIES:
UT Southwestern researchers investigate high-risk populations for bladder-cancer screenings   Bladder cancer patients rarely receive recommended care   Certain Ecologic Factors Associated with Greater Risk of Bladder Cancer   Gene test shows which bladder cancer patients may have cancer spread   Measurement of Urinary Protein Can Help Detect Recurrent Bladder Cancer   Delaying bladder cancer surgery increases mortality   Meat, Especially If It’s Well Done, May Increase Risk of Bladder Cancer   New Investigational Treatment for Bladder Cancer, Identified with New Research Model   The Predictors of Local Recurrence After Radical Cystectomy in Patients with Invasive Bladder Cancer   Radiation does not improve survival for rare, invasive bladder cancer   Consumption of Cultured Milk Products May Reduce Bladder Cancer Risk   AUA releases new guidelines on non-muscle invasive bladder cancer   Not enough evidence for bladder cancer screening   Early menopause related to bladder cancer risk   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   Researcher Says Improved Detection of Bladder Tumors Reduces Cancer Recurrence   Home urine testing cuts bladder cancer deaths   Nearly all patients with high-grade bladder cancer do not receive guideline-recommended care   Patients unaware of link between smoking and bladder cancer   Bladder Cancer Study Determines Optimal Treatment   Variation in prostate stem cell antigen gene raises bladder cancer risk   Scientists find one reason why bladder cancer hits more men

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]